MA30046B1 - Compose heterocyclique hybride - Google Patents

Compose heterocyclique hybride

Info

Publication number
MA30046B1
MA30046B1 MA31024A MA31024A MA30046B1 MA 30046 B1 MA30046 B1 MA 30046B1 MA 31024 A MA31024 A MA 31024A MA 31024 A MA31024 A MA 31024A MA 30046 B1 MA30046 B1 MA 30046B1
Authority
MA
Morocco
Prior art keywords
hybrid
heterocyclic compound
heterocyclic
compound
hybrid heterocyclic
Prior art date
Application number
MA31024A
Other languages
English (en)
Inventor
Tomoyasu Ishikawa
Kazuhiro Miwa
Masaki Seto
Hiroshi Banno
Youichi Kawakita
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of MA30046B1 publication Critical patent/MA30046B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA31024A 2005-12-02 2008-06-11 Compose heterocyclique hybride MA30046B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005349858 2005-12-02
JP2006060648 2006-03-07

Publications (1)

Publication Number Publication Date
MA30046B1 true MA30046B1 (fr) 2008-12-01

Family

ID=37897379

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31024A MA30046B1 (fr) 2005-12-02 2008-06-11 Compose heterocyclique hybride

Country Status (15)

Country Link
US (1) US20100216788A1 (fr)
EP (1) EP1957495A1 (fr)
JP (1) JP2009517333A (fr)
KR (1) KR20080084823A (fr)
AR (1) AR057961A1 (fr)
AU (1) AU2006319787A1 (fr)
BR (1) BRPI0619911A2 (fr)
CA (1) CA2631066A1 (fr)
CR (1) CR10057A (fr)
MA (1) MA30046B1 (fr)
NO (1) NO20082870L (fr)
PE (1) PE20071089A1 (fr)
RU (1) RU2008126949A (fr)
TW (1) TW200730527A (fr)
WO (1) WO2007064045A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20105024B (en) * 2004-06-02 2010-06-25 Takeda Pharmaceuticals Co Fused heterocyclic compound
CN101611041A (zh) * 2006-12-12 2009-12-23 武田药品工业株式会社 稠合杂环化合物
US7825127B2 (en) 2006-12-28 2010-11-02 Takeda Pharmaceutical Company, Limited Method for treating cancer
AU2008264469A1 (en) 2007-06-19 2008-12-24 Takeda Pharmaceutical Company Limited Preventive/remedy for cancer
TW200940546A (en) * 2008-03-03 2009-10-01 Takeda Pharmaceutical Combination drug
UY31704A (es) * 2008-03-12 2009-11-10 Takeda Pharmaceutical Compuesto heterociclico fusionado
BR112013032813A2 (pt) 2011-06-20 2016-08-16 Du Pont composto de fórmula, composição e método para o tratamento, controle, prevenção ou proteção dos animais contra a infecção por helmintos
EP2844247A4 (fr) * 2012-04-20 2015-11-25 Anderson Gaweco Modulateurs de ror et leurs utilisations
AU2014296261B2 (en) * 2013-07-31 2018-11-15 Merck Patent Gmbh Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
GB201520499D0 (en) * 2015-11-20 2016-01-06 Medical Res Council Technology Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
GEP20105024B (en) * 2004-06-02 2010-06-25 Takeda Pharmaceuticals Co Fused heterocyclic compound
RU2007107167A (ru) * 2004-07-30 2008-09-10 Метилджин, Инк. (Ca) Ингибиторы передачи сигнала рецептора vegf и рецептора hgf
TW200740820A (en) * 2005-07-05 2007-11-01 Takeda Pharmaceuticals Co Fused heterocyclic derivatives and use thereof

Also Published As

Publication number Publication date
PE20071089A1 (es) 2007-11-19
CR10057A (es) 2008-07-29
TW200730527A (en) 2007-08-16
BRPI0619911A2 (pt) 2016-08-30
AU2006319787A1 (en) 2007-06-07
KR20080084823A (ko) 2008-09-19
US20100216788A1 (en) 2010-08-26
JP2009517333A (ja) 2009-04-30
CA2631066A1 (fr) 2007-06-07
RU2008126949A (ru) 2010-01-10
NO20082870L (no) 2008-09-01
WO2007064045A1 (fr) 2007-06-07
EP1957495A1 (fr) 2008-08-20
AR057961A1 (es) 2007-12-26

Similar Documents

Publication Publication Date Title
DK1919907T5 (da) Heterocyklisk forbindelse
MA30046B1 (fr) Compose heterocyclique hybride
FR2889375B1 (fr) Structure resonnante hybride
DK1937650T3 (da) Heterocykliske forbindelser
ZA200709051B (en) Heterocyclic compound
CY2013047I1 (el) Ενωσεις διαρυλυδαντοϊνης
BRPI0718266A2 (pt) Compostos heterocíclicos como agentes anti-inflamatórios.
DK1931713T3 (da) Aryl-/alkylravsyreanhydridhyaluronderivater
DE602006015453D1 (de) Bleibatterie
DE602006018404D1 (de) Batteriepack
FI20055630A0 (fi) Kasvonaamio
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE469058T1 (de) Zigarettenpackung
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
CR10039A (es) Derivados espirocíclicos
DK1971588T3 (da) Tiglien-3-onderivater
DE602006015298D1 (de) Superlegierungspulver
NO20070299L (no) Novel heterocyclic compounds
FR2894580B1 (fr) Materiau hybride organique-inorganique mesostructure
DE602006014973D1 (de) Neuartige cercosporamidderivate
DE602004019700D1 (de) Peer-to-peer auf zonenbasis
ZA200800142B (en) Heterocyclic compound
DE502006006543D1 (de) Werkzeughalter
ATE541837T1 (de) Oxaphenanthren-derivate